Cargando…
Examining the Inclusivity of US Trials of COVID-19 Treatment
Autores principales: | Chokkara, Sukarn, Volerman, Anna, Ramesh, Siddhi, Laiteerapong, Neda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840067/ https://www.ncbi.nlm.nih.gov/pubmed/33506396 http://dx.doi.org/10.1007/s11606-020-06566-8 |
Ejemplares similares
-
Evaluation of Faculty Parental Leave Policies at Medical Schools Ranked by US News & World Report in 2020
por: Slostad, Jessica, et al.
Publicado: (2023) -
Bare necessities? The utility of full skin examination in the COVID‐19 era
por: O’Connor, C., et al.
Publicado: (2021) -
Commercial COVID-19 PCR Test Price in US Hospitals
por: Jiang, John Xuefeng, et al.
Publicado: (2023) -
Age and beliefs about vaccines associated with COVID-19 vaccination among US Veterans
por: Wilson, Geneva M., et al.
Publicado: (2023) -
Mental Health of US Medical Students During the COVID-19 Pandemic
por: Christophers, Briana, et al.
Publicado: (2021)